The diabetes patients have been associated with an increased risk of mortality by breast cancer, and there are diŠer-ences in the regimen choice and eŠects of breast cancer treatment between the breast cancer patients with diabetes and their nondiabetic counterparts. However, the pathophysiological relationships of diabetes and breast cancer have not yet been elucidated in detail, therefore its evaluation is strongly required to achieve novel treatment strategies for breast cancer with hyperglycemia. Extracellular circumstances of cancer cells can in‰uence the growth and behavior, resulting in invasion, metastasis and tumor development. We demonstrated that breast cancer cells, MCF-7, cultured in hyperglycemic level signiˆcantly promotes the motile activity in comparison to normal physiological glucose level. Moreover, Zn 2＋ uptake activity into cellular cytosol and the mRNA expression of zinc transporters, ZIP6 and ZIP10, in the high glucose-exposed cells were shown to be especially higher than in the physiological glucose level. The depletion of intracellular Zn 2＋ by zinc chelation and ZIP6 or ZIP10 knockdown blocked the high migration activity, indicating that Zn 2＋ transported via ZIP6 and ZIP10 plays an essential role in the promotion of cell motility stimulated in high glucose level. Theseˆndings provide a proposing target of the novel strategies for the diagnosis and therapy of breast cancer with hyperglycemia.
Patients with breast cancer and diabetes were more likely to receive surgery and hormonal therapy than their nondiabetic counterparts (p＜ 0.05). 
